0001104659-11-036010.txt : 20110622 0001104659-11-036010.hdr.sgml : 20110622 20110622164045 ACCESSION NUMBER: 0001104659-11-036010 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110517 FILED AS OF DATE: 20110622 DATE AS OF CHANGE: 20110622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Radius Health, Inc. CENTRAL INDEX KEY: 0001428522 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 800145732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 425 9225 MAIL ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: MPM ACQUISITION CORP DATE OF NAME CHANGE: 20080228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ipsen, S.A. CENTRAL INDEX KEY: 0001370483 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53173 FILM NUMBER: 11925937 BUSINESS ADDRESS: STREET 1: 42, RUE DU DOCTEUR BLANCHE CITY: PARIS STATE: I0 ZIP: 75016 BUSINESS PHONE: 011 33144961010 MAIL ADDRESS: STREET 1: 42, RUE DU DOCTEUR BLANCHE CITY: PARIS STATE: I0 ZIP: 75016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ipsen Pharma SAS CENTRAL INDEX KEY: 0001523587 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53173 FILM NUMBER: 11925938 BUSINESS ADDRESS: STREET 1: 65 QUAI GEORGES GORSE CITY: BOULOGNE BILLANCOURT STATE: I0 ZIP: 92100 BUSINESS PHONE: 33 1 58 33 50 00 MAIL ADDRESS: STREET 1: 65 QUAI GEORGES GORSE CITY: BOULOGNE BILLANCOURT STATE: I0 ZIP: 92100 3 1 a3.xml 3 X0203 3 2011-05-17 0 0001428522 Radius Health, Inc. NONE 0001523587 Ipsen Pharma SAS C/O WILLY MATHOT, GENERAL COUNSEL 65, QUAI GEORGES GORSE BOULOGNE BILLANCOURT I0 92100 FRANCE 0 0 1 0 0001370483 Ipsen, S.A. C/O WILLY MATHOT, GENERAL COUNSEL 65, QUAI GEORGES GORSE BOULOGNE BILLANCOURT I0 92100 FRANCE 0 0 0 1 Possible 10% beneficial owner Series A-1 Convertible Preferred Stock Common Stock 173260 D Ipsen Pharma, a societe par actions simplifiee organized under the laws of France (Ipsen Pharma), is a wholly-owned subsidiary of Ipsen, a societe anonyme organized under the laws of France (Ipsen). Accordingly, Ipsen may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly by Ipsen Pharma. This Form 3 is filed jointly by Ipsen Pharma and Ipsen. Neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission that Ipsen Pharma and Ipsen are, for the purposes of Sections 13(d), 13(g) or 16 of the Securities Exchange Act of 1934, as amended (the Act), or for any other purpose, the beneficial owners of any securities. Pursuant to Rule 13d-4 of the Act, Ipsen disclaims beneficial ownership of the shares of the Issuer held by Ipsen Pharma. Ipsen does not have or share a pecuniary interest in the shares of the Issuer held by Ipsen Pharma for purposes of Rule 16a-1(a)(2) under the Act. Each share of Series A-1 Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion ratio of 10 shares of Common Stock for every 1 share of Preferred Stock. /s/ WILLY MATHOT 2011-06-21 /s/ WILLY MATHOT 2011-06-21